div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imagea href=https:reader039fdocumentecomreader039viewer20220331225e31638c7f7a9b00971bd473html5page1jpg target=_blank img data-url=document33-n-lipsa-responsabilului-cu-farmacovigilenta-sarcinile-privind-monitorizareahtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: romvacroromvacroPOS-F5-001_Monitorizare_RA_rev02pdf · 33 În lipsa Responsabilului cu Farmacovigilenta sarcinile privind monitorizarea reactiilor adverse vor fi preluate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader039fdocumentecomreader039viewer20220331225e31638c7f7a9b00971bd473html5thumbnails1jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imagea href=https:reader039fdocumentecomreader039viewer20220331225e31638c7f7a9b00971bd473html5page2jpg target=_blank img data-url=document33-n-lipsa-responsabilului-cu-farmacovigilenta-sarcinile-privind-monitorizareahtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: romvacroromvacroPOS-F5-001_Monitorizare_RA_rev02pdf · 33 În lipsa Responsabilului cu Farmacovigilenta sarcinile privind monitorizarea reactiilor adverse vor fi preluate loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader039fdocumentecomreader039viewer20220331225e31638c7f7a9b00971bd473html5thumbnails2jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imagea href=https:reader039fdocumentecomreader039viewer20220331225e31638c7f7a9b00971bd473html5page3jpg target=_blank img data-url=document33-n-lipsa-responsabilului-cu-farmacovigilenta-sarcinile-privind-monitorizareahtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3:...